Open AccessMedicare Spending and Potential Savings on Brand-Name Drugs With Available Generic Substitutes Excluded by 2 Large Pharmacy Benefit Managers, 2012 Through 2015
Author(s) -
Alexander C. Egilman,
Joshua D. Wallach,
Joseph S. Ross,
Sanket S. Dhruva
Publication year - 2018
Publication title -
jama internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.14
H-Index - 342
eISSN - 2168-6114
pISSN - 2168-6106
DOI - 10.1001/jamainternmed.2017.8016
Subject(s) - medicine , pharmacy , brand names , medicare part d , medline , marketing , family medicine , pharmacology , prescription drug , medical prescription , business , political science , law
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom